Prospective, Single-Arm, Longitudinal Study of Biomarkers in Real-World Patients with Severe Asthma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prospective, Single-Arm, Longitudinal Study of Biomarkers in Real-World Patients with Severe Asthma

Published:2020-09 Issue:8 Volume:8 Page:2630-2639.e6
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Buhl Roland,Korn Stephanie,Menzies-Gow Andrew,Aubier Michel,Chapman Kenneth R.,Canonica Giorgio W.,Picado César,Donica Margarita,Kuhlbusch Klaus,Korom Stephan,Hanania Nicola A.

Funder

F. Hoffmann-La Roche Ltd

Boehringer Ingelheim

GSK

Novartis

Roche

AstraZeneca

Takeda

MedImmune

Teva

Boston Scientific

Chiesi

Amgen

Baxter

CSL Behring

Forest Labs

Grifols

Merck Frosst

Pfizer

Canadian Institutes of Health Research

Canadian Cohort Obstructive Lung Disease

University Health Network

Almirall

ALK-Abellό

Allergopharma

Allergy Therapeutics

Lofarma

Mundipharma

Novartis, Stallergenes Greer

Thermo Fisher

Laboratorios LETI

Mylan

Peter Button of Roche Products Pty Ltd

Nosheen Rasul of F. Hoffmann-La Roche Ltd

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference20 articles.

1. Anti-IL5 therapies for asthma;Farne;Cochrane Database Syst Rev,2017

2. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma;Katsaounou;Respir Med,2019

3. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program;Moore;Am J Respir Crit Care Med,2010

4. Asthma: defining of the persistent adult phenotypes;Wenzel;Lancet,2006

5. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease;Anderson;Lancet,2008

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population;The Journal of Allergy and Clinical Immunology: In Practice;2024-05

2. Machine Learning Approaches to Predict Asthma Exacerbations: A Narrative Review;Advances in Therapy;2023-12-19

3. Mild asthma is not mild: risk factors and predictive biomarkers for severe acute exacerbations and progression in mild asthma;Expert Review of Respiratory Medicine;2023-12-02

4. Consensus on the management of united airways disease with type 2 inflammation: a multidisciplinary Delphi study;Allergy, Asthma & Clinical Immunology;2023-04-23

5. Periostin as an important biomarker of inflammatory phenotype T2 in Brazilian asthma patients;Jornal Brasileiro de Pneumologia;2023-01-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3